Spectral domain optical coherence tomography imaging of mucopolysaccharidoses I, II, IV A, and VI

  • Yuan-Chieh LeeEmail author
Letter to the Editor


Enzyme Replacement Therapy Retinitis Pigmentosa Cystoid Macular Edema Optical Coherence Tomography Imaging Outer Nuclear Layer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Conflict of interest

The author certifies that he has NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Informed patient consent and IRB approval (IRB103-162-A) were obtained for the study.


  1. 1.
    Seok S, Lyu IJ, Park KA, Oh SY (2015) Spectral domain optical coherence tomography imaging of mucopolysaccharidoses I, II, and VI A. Graefes Arch Clin Exp Ophthalmol. doi: 10.1007/s00417-015-2953-y/fulltext.html Google Scholar
  2. 2.
    Huang CT, Chu SY, Lee YC (2015) Optical coherence tomography of chorioretinopathy caused by mucopolysaccharidoses. Ophthalmology. doi: 10.1016/j.ophtha.2015.01.015 Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Department of OphthalmologyBuddhist Tzu Chi General HospitalHualienTaiwan
  2. 2.Department of Ophthalmology and Visual ScienceTzu Chi UniversityHualienTaiwan
  3. 3.Institute of Medical ScienceTzu Chi UniversityHualienTaiwan
  4. 4.Department of OphthalmologyNational Taiwan University HospitalTaipeiTaiwan

Personalised recommendations